Tact.ai, the human-friendly CRM company, today announced it has been named as a Voice-Driven Sales App Sample Vendor in Gartner’s Hype Cycle for Life Sciences Commercial Operations, 2020. Tact.ai was also named as a sample Vendor for three up and coming technologies – Voice-Driven Sales Apps, Sales Bots, and Mobile Sales Productivity – in Gartner’s Hype Cycle for CRM Sales Technology, 2020.
A Gartner subscription is required to access these reports.
“Life Science companies are facing unprecedented commercialization model disruption due to the COVID-19pandemic. This has forced companies to rapidly shift their digital initiatives from planning to execution, highlighting the need for agility over completeness,” Gartner reports.
For Tact.ai customers in pharmaceuticals, already scarce in-person meetings with physicians have become nearly impossible to get because of restricted access to doctor’s offices and hospitals. As a result, advanced planning and follow up on virtual visits and digital interactions with physicians has become more important.
Tact.ai puts people first with human-friendly CRM solutions that are prescriptive, omnichannel, and frictionless. Powered by our patented Edge AI platform, Tact improves engagement, sales behaviour and effectiveness for your reps, customers and account teams.
Gartner says that “the COVID-19 pandemic will accelerate the pace of adoption of sales technologies that can help improve digital engagement efforts with buyers”. The Gartner Hype Cycle for CRM and sales Technologies, 2020 report says that, in general, “Sales organizations can no longer expect the extended face time afforded to their reps in on-site meetings and must reevaluate technological investments to prepare for a strategic shift in how they will sell in the near term and long term.” Within the Hype Cycle for CRM Sales Technology report, Tact is referenced in three categories:
• Voice-Driven Sales Apps: “When effectively deployed, such implementations can improve individual productivity by offering a more accessible alternative for documenting sales activities and outcomes, thus freeing up more time for selling.”
• Sales Bots: “This technology has broad application to all B2B, B2C and indirect sales use cases, ranging from automating data capture with vocal user interfaces, or parsing telephone calls for a contextual meeting.”
• Mobile Sales Productivity: “Mobile sales productivity apps will increase sales adoption and improve data quality by using a less intrusive approach to collecting sales data.”
“Commercial teams have experienced massive transformation due to restricted access to HCPs, with today’s new normal meaning limited in-person appointments and the need for more digital and omnichannel engagement,” said Chuck Ganapathi, founder and CEO of Tact.ai. “We’re thankful to work with pharmaceutical and medical device leaders to reimagine the commercial and HCP experience, delivering new ways for them to work with their customers and nurture more meaningful conversations.” Sources:
Gartner "Hype Cycle for CRMSales Technology, 2020," Adnan Zijadic, Theodore (Tad) Travis, Melissa Hilbert, 16 July 2020
Gartner “Hype Cycle for LifeScience Commercial Operations, 2020,” Animesh Gandhi, Michael Shanler, 6 August 2020
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's Research and Advisory organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
BASE life science is an innovative and forward-thinking technology, product and service consultancy specialized in creating real business value from digital platforms and data. Our experienced teams are ready to help optimize your technology and business processes within Customer Engagement, Quality, Regulatory, Compliance and Clinical data management.
Tact.ai is on a mission to help life science organizations nurture meaningful customer engagement through our human-friendly software. Our AI-powered engagement platform empowers field teams to work with their customers in new ways to drive better outcomes. Tact.ai is headquartered in Silicon Valley and is backed by some of the world’s leading firms in venture capital, technology, and healthcare and life sciences, including Microsoft’s venture fund M12, Salesforce Ventures, Novartis, Lilly and McKesson Ventures. Visit us at: https://www.tact.ai/